Croda

13. March 2017 Background Medicines used in neonates contain different excipients, which may not be safe in this age group. Objective To...

22. February 2017 Abstract Objective: Fast melt tablets and sublingual route have been widely used for providing quick onset of...

07. February 2017 INTRODUCTION: The pharmacokinetics of excipients in neonates differs from that of older children. In a recent pan--European...

17. November 2016 Abstract Amorphous state of drugs increases the oral bioavailability, but typically faces physical stability problems. Amorphous rutin...

  Abstract Solid lipid microparticles (SLM) were produced by produced by a two-step process that, firstly, involved the emulsification of...

28. April 2016 Our objectives were to explore the possibility of avoiding neonatal exposure to potentially harmful excipients of interest...

25. February 2016 The STEP stands for Safety and Toxicity of Excipients for Paediatrics. It is a user-designed resource developed by European Paediatric Formulation...

Objective: We aimed to describe administration of eight potentially harmful excipients of interest (EOI)-parabens, polysorbate 80, propylene glycol, benzoates, saccharin sodium,...

22. September 2015 Syloid® XDP silica: Carrier for liquid drug solubilizers in solid dosage form. The solubility of poorly soluble...

Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at Mevisa, Spain. Croda,...